| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 30, 2008
From the Department of Neuroscience (T.M.H., P.D.L.), University of California, San Diego, San Diego, Calif; and the Department of Veterans' Affairs San Diego (P.D.L.), San Diego, Calif. * To whom correspondence should be addressed. E-mail: themmen{at}ucsd.edu.
Abstract—Neuroprotective therapies have so far failed to provide improved neurological function and outcome after stroke. A recent focus on multimodal therapies, including the combination of neuroprotective medications with hypothermia, opens a promising new treatment strategy. Advances in hypothermia administration make it one of the most promising neuroprotective therapies available and an ideal candidate for combination with other neuroprotective approaches.
Accepted on August 6, 2008
Multimodal Neuroprotective Therapy With Induced Hypothermia After Ischemic Stroke
Thomas M. Hemmen MD, PhD* and Patrick D. Lyden MD, FAAN
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |